Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium | Zendy

Nassim Kamar | Zendy; Loubna Oufroukhi | Zendy; Patrick Fauré | Zendy; David Ribes | Zendy; Olivier Cointault | Zendy; Laurence Lavayssière | Zendy; Marie Béatrice Nogier | Zendy; Laure Esposito | Zendy; D. Durand | Zendy; Lionel Rostaing | Zendy

Open Access

Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium

Author(s) -

Nassim Kamar,

Loubna Oufroukhi,

Patrick Fauré,

David Ribes,

Olivier Cointault,

Laurence Lavayssière,

Marie Béatrice Nogier,

Laure Esposito,

D. Durand,

Lionel Rostaing

Publication year - 2005

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfi009

Subject(s) - mycophenolate , medicine , mycophenolic acid , enteric coated , renal transplant , adverse effect , gastroenterology , transplantation

Gastrointestinal (GI) disorders are one of the main adverse events in patients treated by mycophenolic acid (MPA). The aim of our prospective questionnaire-based study was to assess GI side-effects in de novo renal-transplant patients receiving either mycophenolate mofetil (MMF) or enteric-coated mycophenolate sodium (EC-MPS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research